Looking for the B2B SaaS growth agency? We are now over at Growigami.com
← All Stories
Fundraising

Canton Strategic Holdings Files Form D with SEC

Canton Strategic Holdings, Inc. submitted a Form D filing to the SEC on April 15, 2026, for an exempt securities offering in the pharmaceutical sector.

Professional business conference presentation with diverse participants engaging in communication.
Photo by Pavel Danilyuk on Pexels

Canton Strategic Holdings Submits SEC Form D Filing

Canton Strategic Holdings, Inc., with CIK number 0001861657, filed a Form D on April 15, 2026, as a notice of an exempt offering under the Securities Act of 1933, according to SEC EDGAR. The filing, assigned accession number 0001493152-26-016735, is sized at 13 KB and relates to the company’s activities in pharmaceutical preparations.

Filing Details

The Form D filing specifies that Canton Strategic Holdings, Inc. operates under EIN 842642541 and is incorporated in Delaware, with a fiscal year ending on December 31. According to SEC EDGAR, the filing includes file number 021-580535 and film number 26863351, and it falls under SIC code 2834 for pharmaceutical preparations. The CF Office classification is 03 Life Sciences, indicating the company’s focus within that sector.

Company and Regulatory Context

Canton Strategic Holdings, Inc. is classified under the Life Sciences office in the filing, which aligns with widely-known practices where companies in pharmaceuticals use Form D for exempt offerings. As a widely-known regulatory tool, Form D allows issuers to raise capital through private placements, though specific details on the offering are limited to the facts in this filing, according to SEC EDGAR.

Sources
Topics
Get capital raising signals before they hit the news.
Join Waitlist